Specific electrocardiographic features associated with Cushing's disease

Clinical Endocrinology

Volumn 74, Issue 5, 2011, Pages 558-564

  Alexandraki, Krystallenia I ^a   Kaltsas, Gregory A ^a,b   Vouliotis, Apostolos Ilias ^c   Papaioannou, Theodoros G ^c   Trisk, Lauren ^a   Zilos, Athanasios ^b   Korbonits, Márta ^a   Besser, G Michael ^a   Anastasakis, Aris ^c   Grossman, Ashley B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARBOHYDRATE ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CUSHING DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERCORTISOLISM; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; QT DISPERSION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79953760528     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.03975.x     Document Type: Article

References (51)

1. Etxabe, J., &, Vazquez, J.A., (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology (Oxf), 40, 479-484. (Pubitemid 24194645)
2. Mancini, T., Kola, B., Mantero, F., et al. (2004) High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clinical Endocrinology (Oxf), 61, 768-777. (Pubitemid 40006799)
3. Fallo, F., &, Sonino, N., (2009) Should we evaluate for cardiovascular disease in patients with Cushing's syndrome? Clinical Endocrinology (Oxf), 71, 768-771.
4. Sylven, C., Jansson, E., Sotonyi, P., et al. (1996) Cardiac nuclear hormone receptor mRNA in heart failure in man. Life Science, 59, 1917-1922. (Pubitemid 26381156)
5. Christ-Crain, M., Kola, B., Lolli, F., et al. (2008) AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB Journal, 22, 1672-1683. (Pubitemid 351811445)
6. Muiesan, M.L., Lupia, M., Salvetti, M., et al. (2003) Left ventricular structural and functional characteristics in Cushing's syndrome. Journal of the American College of Cardiology, 41, 2275-2279. (Pubitemid 36724279)
7. Ritchie, C.M., Sheridan, B., Fraser, R., et al. (1990) Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly. The Quarterly Journal of Medicine, 76, 855-867. (Pubitemid 20244075)
8. Malik, M., &, Batchvarov, V.N., (2000) Measurement, interpretation and clinical potential of QT dispersion. Journal of the American College of Cardiology, 36, 1749-1766.
9. Barr, C.S., Naas, A., Freeman, M., et al. (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet, 343, 327-329. (Pubitemid 24043180)
10. Sahu, P., Lim, P.O., Rana, B.S., et al. (2000) QT dispersion in medicine: electrophysiological holy grail or fool's gold? The Quarterly Journal of Medicine, 93, 425-431. (Pubitemid 30459920)
11. Darbar, D., Luck, J., Davidson, N., et al. (1996) Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. British Medical Journal, 312, 874-878. (Pubitemid 126443429)
12. Moreno, F.L., Villanueva, T., Karagounis, L.A., et al. (1994) Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators. Circulation, 90, 94-100. (Pubitemid 24203667)
13. Cardoso, C.R., Salles, G.F., &, Deccache, W., (2003) Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. Journal of Diabetes and its Complications, 17, 169-178. (Pubitemid 37297397)
14. Rana, B.S., Band, M.M., Ogston, S., et al. (2002) Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. American Journal of Cardiology, 90, 483-487. (Pubitemid 35246036)
15. Dekker, J.M., Schouten, E.G., Klootwijk, P., et al. (1994) Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation, 90, 779-785. (Pubitemid 24242745)
16. Veglio, M., Bruno, G., Borra, M., et al. (2002) Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. Journal of Internal Medicine, 251, 317-324. (Pubitemid 34592105)
17. Okin, P.M., Devereux, R.B., Howard, B.V., et al. (2000) Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation, 101, 61-66. (Pubitemid 30039077)
18. de Bruyne, M.C., Hoes, A.W., Kors, J.A., et al. (1999) Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. European Heart Journal, 20, 278-284. (Pubitemid 29082148)
19. Christensen, P.K., Gall, M.A., Major-Pedersen, A., et al. (2000) QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scandinavian Journal of Clinical and Laboratory Investigation, 60, 323-332. (Pubitemid 30616615)
20. Naas, A.A., Davidson, N.C., Thompson, C., et al. (1998) QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. British Medical Journal, 316, 745-746. (Pubitemid 28121074)
21. Alexandraki, K.I., &, Grossman, A.B., (2010) Medical therapy of Cushing's disease: where are we now? Frontiers of Hormone Research, 38, 165-173.
22. Alexandraki, K.I., Kaltsas, G.A., Isidori, A.M., et al. (2009) The prevalence and characteristic features of cyclicity and variability in Cushing's disease. European Journal of Endocrinology, 160, 1011-1018.
23. Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-1645.
24. Macfarlane, P.W., McLaughlin, S.C., Devine, B., et al. (1994) Effects of age, sex, and race on ECG interval measurements. Journal of Electrocardiology 27 (Suppl.), 14-19. (Pubitemid 124034255)
25. Kautzner, J., Yi, G., Camm, A.J., et al. (1994) Short- and long-term reproducibility of QT, QTc, and QT dispersion measurement in healthy subjects. Pacing and Clinical Electrophysiology: PACE, 17, 928-937. (Pubitemid 24141007)
26. Bazett, H.C., (1920) An analysis of time relations of the electrocardiogram. Heart, 7, 353-370.
27. Lanjewar, P., Pathak, V., &, Lokhandwala, Y., (2004) Issues in QT interval measurement. Indian Pacing and Electrophysiology Journal, 4, 156-161. (Pubitemid 41085893)
28. Hnatkova, K., Malik, M., Kautzner, J., et al. (1994) Adjustment of QT dispersion assessed from 12 lead electrocardiograms for different numbers of analysed electrocardiographic leads: comparison of stability of different methods. British Heart Journal, 72, 390-396. (Pubitemid 24322955)
29. de Bruyne, M.C., Hoes, A.W., Kors, J.A., et al. (1998) QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation, 97, 467-472. (Pubitemid 28090219)
30. Galinier, M., Balanescu, S., Fourcade, J., et al. (1997) Prognostic value of ventricular arrhythmias in systemic hypertension. Journal of Hypertension, 15, 1779-1783. (Pubitemid 28029681)
31. Newell-Price, J., Bertagna, X., Grossman, A.B., et al. (2006) Cushing's syndrome. Lancet, 367, 1605-1617. (Pubitemid 43674231)
32. Hancock, E.W., Deal, B.J., Mirvis, D.M., et al. (2009) AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy. A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. Journal of the American College of Cardiology, 53, 992-1002.
33. Alfakih, K., Walters, K., Jones, T., et al. (2004) New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension, 44, 175-179. (Pubitemid 39014235)
34. Colao, A., Pivonello, R., Spiezia, S., et al. (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism, 84, 2664-2672. (Pubitemid 30641990)
35. Barahona, M.J., Sucunza, N., Resmini, E., et al. (2009) Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 94, 3365-3371.
36. Ichkhan, K., Molnar, J., &, Somberg, J., (1997) Relation of left ventricular mass and QT dispersion in patients with systemic hypertension. American Journal of Cardiology, 79, 508-511. (Pubitemid 127440424)
37. Kulan, K., Ural, D., Komsuoglu, B., et al. (1998) Significance of QTc prolongation on ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension. International Journal of Cardiology, 64, 179-184. (Pubitemid 28275558)
38. Saadeh, A., Evans, S., James, M., et al. (1999) QTc dispersion and complex ventricular arrhythmias in untreated newly presenting hypertensive patients. Journal of Human Hypertension, 13, 665-669. (Pubitemid 29481485)
39. Wei, K., Dorian, P., Newman, D., et al. (1995) Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. Journal of the American College of Cardiology, 26, 859-863.
40. Tsuiki, M., Tanabe, A., Takagi, S., et al. (2008) Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocrine Journal, 55, 737-745.
41. Glancy, J.M., Weston, P.J., Bhullar, H.K., et al. (1996) Reproducibility and automatic measurement of QT dispersion. European Heart Journal, 17, 1035-1039. (Pubitemid 26252521)
42. Elming, H., Holm, E., Jun, L., et al. (1998) The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. European Heart Journal, 19, 1391-1400. (Pubitemid 28427142)
43. Torpy, D.J., Mullen, N., Ilias, I., et al. (2002) Association of hypertension and hypokalemia with Cushing's Syndrome Caused by Ectopic ACTH Secretion. Annals of the New York Academy of Science, 970, 134-144. (Pubitemid 35286090)
44. Pitt, B., Williams, G., Remme, W., et al. (2001) The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovascular Drugs and Therapy, 15, 79-87. (Pubitemid 32684565)
45. Pitt, B., Zannad, F., Remme, W.J., et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine, 341, 709-717. (Pubitemid 29407370)
46. Fraccarollo, D., Galuppo, P., &, Bauersachs, J., (2004) Mineralocorticoid receptor antagonism and cardiac remodeling in ischemic heart failure. Current Medicinal Chemistry. Cardiovascular and Hematological Agents, 2, 287-294. (Pubitemid 39200173)
47. Mihailidou, A.S., Loan Le, T.Y., Mardini, M., et al. (2009) Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54 (6), 1306-1312.
48. Funder, J.W., (2009) Reconsidering the roles of the mineralcorticoid receptor. Hypertension 53 (part 2), 286-290.
49. Gonzalez, C.D., de Sereday, M., Sinay, I., et al. (2010) Endocrine therapies and QTc prolongation. Current Drug Safety, 5, 79-84.
50. Del Rosario, M.E., Weachter, R., &, Flaker, G.C., (2010) Drug-induced QT prolongation and sudden death. Missouri Medicine 107 (1), 53-58.
51. Salle, P., Rey, J.L., Bernasconi, P., et al. (1985) Torsades de pointe. Apropos of 60 cases. Annales de Cardiologie et d'angéiologie 34 (6), 381-388.